SGPL · S.G. Power Limited
Transmission of Annual Report for the Year Ended June 30, 2026.
- Filed
- 8 October 2026 at 12:33 pm
- Category
- Financials
- Sentiment
- Neutral
- Impact
- High
AI executive summary
Crestwell Healthcare Limited (formerly S.G. Power Limited) transmitted its annual report for the year ended June 30, 2026, reporting a net loss after tax of PKR 8.21 million following the discontinuation of its historical power operations and transition into the pharmaceutical and healthcare sector. The company completed a 300% rights issue subsequent to the year-end, raising PKR 534.99 million to strengthen its capital base.
Key takeaways
- Revenue from the discontinued power segment was nil for FY2026 compared to PKR 6.15 million in FY2025.
- Loss after tax for the year stood at PKR 8.21 million compared to a loss of PKR 8.40 million in FY2025.
- Basic and diluted loss per share was PKR 0.46 for FY2026 compared to PKR 0.47 in the preceding year.
- The Board did not recommend any dividend for the year ended June 30, 2026, due to accumulated losses.
- The company changed its name from S.G. Power Limited to Crestwell Healthcare Limited and shifted its principal business to healthcare and pharmaceuticals.
- Subsequent to the year-end, the company issued 300% right shares comprising 53,499,600 ordinary shares at par value of PKR 10 each, aggregating to PKR 534.99 million.
Filing details
Financial results
Annual · Audited · Standalone · 30 June 2026
Figures in PKR
Reporting period
Year
- Income
- 0 (prior 6,145,860)
- Profit after tax
- -8,207,885 (prior -8,404,648)
- EPS
- -0.46 (prior -0.47)
- Changed company name from S.G. Power Limited to Crestwell Healthcare Limited effective August 06, 2026.
- Changed principal line of business from power generation to importing, manufacturing, marketing, and distribution of pharmaceutical and medical equipment products.
- Increased authorized share capital from PKR 200 million to PKR 800 million.
- Completed issuance of 300% right shares (53,499,600 ordinary shares at PKR 10 each) aggregating to PKR 534.99 million subsequent to the year-end.
- Recommended appointment of M/s. Parker Russell-A.J.S., Chartered Accountants, as statutory auditors for the year ending June 30, 2027, subject to AGM approval.
Dividend and entitlement
- Type
- None
- Notes
- The document is only for the transmission of Annual Financial Statements and does not declare any dividend, bonus, or rights entitlement.
- #annual report
- #financial results
- #name change
- #rights issue
- #healthcare sector transition
This summary is AI-generated and may contain errors or omissions. Review the official PSX filing before making an investment decision.